GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » Inventories, Raw Materials & Components

Novomics Co (XKRX:283100) Inventories, Raw Materials & Components : ₩1.1 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Novomics Co Inventories, Raw Materials & Components?

Novomics Co's inventories, raw materials & components for the quarter that ended in Dec. 2024 was ₩1.1 Mil.

Novomics Co's quarterly raw materials declined from Dec. 2022 (₩35.5 Mil) to Dec. 2023 (₩7.9 Mil) and declined from Dec. 2023 (₩7.9 Mil) to Dec. 2024 (₩1.1 Mil).

Novomics Co's annual raw materials declined from Dec. 2022 (₩35.5 Mil) to Dec. 2023 (₩7.9 Mil) and declined from Dec. 2023 (₩7.9 Mil) to Dec. 2024 (₩1.1 Mil).


Novomics Co Inventories, Raw Materials & Components Historical Data

The historical data trend for Novomics Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novomics Co Inventories, Raw Materials & Components Chart

Novomics Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 72.04 44.41 35.46 7.91 1.12

Novomics Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial 72.04 44.41 35.46 7.91 1.12

Novomics Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Novomics Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » Inventories, Raw Materials & Components
Traded in Other Exchanges
N/A
Address
171 Dangsan-ro, 304, 305, 306, 306-1, Yeongdeungpo-gu, Seoul, KOR
Novomics Co Ltd is a developer of a molecular diagnosis system for cancer treatment.

Novomics Co Headlines

No Headlines